[
    {
        "utterance": "Judith Eisen: Hello everyone. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Hello. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: We are in breakout room one. Oh, which yeah, there's about B5. Do you agree with that? But B4, those are assigned actually. I know. So what I'd like you to do is just take a minute and think about causation. ",
        "annotations": {
            "process management": "The speaker is managing meeting flow by discussing room assignments and instructing the group on what to do next.",
            "ask question": "Judith Eisen asks the group for agreement on the room assignment.",
            "clarify goal": "The speaker clarifies the task objective by instructing the group to think about causation."
        }
    },
    {
        "utterance": "Elizabeth Bess: use that for the basis of our conversation. ",
        "annotations": {
            "develop idea": "Elizabeth is expanding on the idea of using causation as the basis for their conversation.",
            "clarify goal": "Elizabeth is defining what needs to be accomplished by clarifying the objective of their discussion."
        }
    },
    {
        "utterance": "Judith Eisen: fellow. And once we've done that, we need to maybe she had to choose someone or someone can volunteer to take it out and I had to come back and something I need to do whatever assignment I have to do. Okay. ",
        "annotations": {
            "encourage participation": "The speaker invites someone to volunteer for a task.",
            "process management": "The speaker is managing the task assignment process.",
            "assign task": "The speaker is involved in assigning or suggesting tasks for someone."
        }
    },
    {
        "utterance": "Unidentified Speaker: Group four. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Group four. I'll put you in group four. ",
        "annotations": {
            "assign task": "Judith Eisen is assigning a group number to someone, effectively assigning them a role or responsibility.",
            "process management": "This action also contributes to managing the group activities by organizing participants into groups."
        }
    },
    {
        "utterance": "Unidentified Speaker: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Okay. So anyone else? ",
        "annotations": {
            "process management": "Judith Eisen is managing the meeting flow by checking for any other groups or individuals that haven't been assigned or acknowledged yet.",
            "encourage participation": "Judith Eisen is inviting others to contribute or participate by asking if there are any others."
        }
    },
    {
        "utterance": "Judith Eisen: So Alexa, where do you want to go? ",
        "annotations": {
            "encourage participation": "This code applies because Judith Eisen is explicitly inviting Alexa to contribute her thoughts or opinions by asking where she wants to go."
        }
    },
    {
        "utterance": "Unidentified Speaker: Room 22 would be great. ",
        "annotations": {
            "Supportive response": "The speaker is expressing a positive sentiment towards a suggestion (being assigned to Room 22)."
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a very brief acknowledgment without additional content."
        }
    },
    {
        "utterance": "Unidentified Speaker: develops organoid models, organ models from stem cells of the peripheral nervous system, particularly the interior nervous system and we're interested in figuring out how these different interior neurons and these organoids are affected in disease. ",
        "annotations": {
            "signal expertise": "The speaker is explicitly stating their own area of expertise or research focus related to organoid models and the nervous system."
        }
    },
    {
        "utterance": "Unidentified Speaker: So in the gut those would be motility diseases that you know lead to abnormalities in movement of the gut tube and muscle tissue. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by providing more details about motility diseases and their effects on the gut tube and muscle tissue."
        }
    },
    {
        "utterance": "Unidentified Speaker: We're also interested in figuring out how neurological diseases like Parkinson's and Alzheimer's and other neurodegenerative diseases manifest in the interior nervous system. ",
        "annotations": {
            "develop idea": "The speaker is expanding on their previous statement about their research focus on organoid models and their application in studying disease.",
            "clarify goal": "The speaker is clarifying their research goals, specifically aiming to understand how neurological diseases manifest in the interior nervous system."
        }
    },
    {
        "utterance": "Unidentified Speaker: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a simple expression of gratitude."
        }
    },
    {
        "utterance": "Unidentified Speaker: Yeah. ",
        "annotations": {
            "None": "The utterance is too minimal and does not explicitly exhibit any specific behavior described by the other codes."
        }
    },
    {
        "utterance": "Unidentified Speaker: That was that was great. ",
        "annotations": {
            "acknowledge contribution": "The speaker is verbally recognizing another group member's input.",
            "supportive response": "The speaker is expressing a positive evaluation of the previous speaker's contribution."
        }
    },
    {
        "utterance": "Aaron Longbrake: Hi, I'm Aaron Longbrake. I'm at Yale. I'm a neuro immunologist. My research is mainly in multiple sclerosis. Um, and I'm interested in detecting the disease before it has caused damage to the nervous system. So I'm interested in the microbiome both as something that might facilitate some of the genetic environmental interactions that lead to the immune disregulation of MS. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their background and expertise as a neuro immunologist with research mainly in multiple sclerosis."
        }
    },
    {
        "utterance": "Aaron Longbrake: I'm also interested in in it as a biomarker of something that may be able to help us detect when something first starts to go awry that ultimately would lead to autoimmunity. Um so that's my general. ",
        "annotations": {
            "develop idea": "The utterance expands on the speaker's previous idea about their research interests, specifically focusing on the microbiome's role as a biomarker.",
            "signal expertise": "The speaker explicitly states their own expertise or research background related to neuroimmunology and multiple sclerosis."
        }
    },
    {
        "utterance": "Judith Eisen: So are there any. ",
        "annotations": {
            "ask question": "Judith Eisen is seeking information or contributions from others.",
            "encourage participation": "Judith Eisen is inviting others to contribute to the discussion."
        }
    },
    {
        "utterance": "Pamela Chang: Hi, my name is Pamela Chang and I'm a professor at Cornell and Ithaca. Um my lab is interested in developing chemical tools to uh characterize or study the metabolism of the gut microbiome. ",
        "annotations": {
            "signal expertise": "Pamela Chang explicitly states her position as a professor and her lab's research focus, signaling her expertise."
        }
    },
    {
        "utterance": "Pamela Chang: And we also look at small molecule metabolites that bacteria in the gut make that modulate. ",
        "annotations": {
            "develop idea": "Pamela is expanding on her previous statement about her lab's interests, providing more details about their research focus.",
            "signal expertise": "Pamela is explicitly stating her and her lab's expertise in studying the gut microbiome and developing chemical tools."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Uh I think I can start sharing some of my thoughts. All right, great. To me, I think in human study, the golden standard to establish causation is to perform a randomized. ",
        "annotations": {
            "propose new idea": "The speaker introduces a new idea about the golden standard for establishing causation in human studies, which is to perform a randomized study."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: I am chemical and biological engineering at Iowa State University. Our interest is in the microbiome and ecosystem where there's a limitation that it wasn't at the level to our. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states his affiliation with chemical and biological engineering at Iowa State University, indicating his expertise.",
            "identify gap": "The speaker mentions 'there's a limitation,' explicitly recognizing a lack or insufficiency in a particular area."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And we know that for some of the micro composition and also micro metabolites that are associated with different factors. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas or knowledge by mentioning specific aspects of microbiome research (micro composition and micro metabolites)."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So in the area of neuroimmunology that came into lab with the observation that specific metabolites can actually ramp up signaling. And if we assume that we're able to find those genetic variants, I actually right now we are able to find some of those people carrying those variants they have a higher level of those micro. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the topic of neuroimmunology by sharing specific observations from their lab about metabolites and genetic variants.",
            "propose new idea": "The speaker introduces new information about specific metabolites ramping up signaling and their relation to genetic variants."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So if that variant is increasing that micro and that variant is also increasing risk of Parkinson's, we can establish a relationship between that micro and. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about the microbiome and its connection to Parkinson's disease by explaining a potential mechanism to establish a relationship between microbiome components and disease risk.",
            "signal expertise": "The speaker is demonstrating expertise in the area of microbiome study, genetic variants, and their potential links to neurological diseases like Parkinson's."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So it's a master in human genetics called randomization is basically using a variant. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous thoughts about genetics and causation, providing more details about a method called randomization in human genetics."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And we can randomize the drug and we can also randomize variants to different and we can test if that variant is associated with a specific. ",
        "annotations": {
            "develop idea": "The speaker is expanding on his previous thoughts about using randomization to establish relationships between genetic variants and disease risks.",
            "signal expertise": "The speaker demonstrates his expertise in genetics and study design, specifically in the use of randomization."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So that it was too long. ",
        "annotations": {
            "express humor": "The speaker is making a humorous comment about their previous statement being too long."
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance or it is too minimal to code"
        }
    },
    {
        "utterance": "Unidentified Speaker: Can I just. ",
        "annotations": {
            "None": "No relevant code fully applies to this utterance."
        }
    },
    {
        "utterance": "Unidentified Speaker: Yes. ",
        "annotations": {
            "None": "No relevant code specifically applies to this simple affirmative response."
        }
    },
    {
        "utterance": "Unidentified Speaker: I put on the comments box. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: The description. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: Of our breakout session and I can. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Unidentified Speaker: Maybe start with asking. ",
        "annotations": {
            "propose new idea": "The speaker is suggesting a new approach for the group to start with asking, which introduces a new method for discussion."
        }
    },
    {
        "utterance": "Lisa Ryno: Yes, I I can. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno: So our permeability changes later correlate with the gut brain axis and the the blood brain barrier and the. ",
        "annotations": {
            "develop idea": "Lisa Ryno is expanding existing ideas by relating her work on permeability changes to the gut-brain axis and the blood-brain barrier."
        }
    },
    {
        "utterance": "Lisa Ryno: And how they're altered during. ",
        "annotations": {
            "ask question": "Lisa Ryno is requesting more information on how permeability changes are altered during a specific context, indicating a need for clarification."
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno: Yeah, that's fine. Um yeah, I I I'm an associate professor of chemistry biochemistry at Oberlin College, which is a small undergraduate in Ohio. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their professional position and affiliation, indicating their expertise in the field.",
            "supportive response": "The speaker begins with a brief acknowledgment of a prior statement, showing agreement or acceptance."
        }
    },
    {
        "utterance": "Lisa Ryno: Um and my lab studies um looking for leverage points inside and outside of the bacterial cell to change biofilm composition and growth. ",
        "annotations": {
            "signal expertise": "Lisa Ryno explicitly states her own expertise and the focus of her lab, which relates to biochemistry and studying bacterial cells."
        }
    },
    {
        "utterance": "Lisa Ryno: So I'm I'm very much a reductionist and I'm thinking about the chemicals, organoids, the brain. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her approach as a reductionist and her focus on chemicals, organoids, and the brain, indicating her expertise."
        }
    },
    {
        "utterance": "Lisa Ryno: And how the high level but when I was I I can expect great discussion about this. So who wants to get started? Simple, fewest variable model system in order to prove causation tends to be a reasonable. ",
        "annotations": {
            "encourage participation": "The speaker invites others to contribute their thoughts or ideas.",
            "propose new idea": "The speaker introduces a suggestion related to their research approach, specifically about methodologies for proving causation."
        }
    },
    {
        "utterance": "Judith Eisen: Maybe I should ask the next question. ",
        "annotations": {
            "process management": "Judith Eisen is suggesting she will ask the next question, which is an attempt to manage the flow of the meeting."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: bacteria that produce there's a lot of molecules all of those I don't know the changes and common to make also another small appreciate that study about so so in humans they are direct correlation so we went after some of those genetically right so you can go actually and target pathways that are indirectly actually related to barriers and that in the end if you have actually my you can affect the blood brain. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by discussing specific approaches to studying the impact of bacteria on the blood-brain barrier.",
            "supportive response": "The speaker's discussion can be seen as supportive of previous ideas or discussions."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: everything that is in your gut what size molecules can actually get into the brain, right? Which is important as well. ",
        "annotations": {
            "ask question": "Judith Eisen is requesting information or clarification on what size molecules can get into the brain from the gut."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So I I couldn't find I couldn't find very actually. So so we had to design some systems but I'm I'm looking actually to find good in both directions and work towards the the middle or do you expect. ",
        "annotations": {
            "develop idea": "She is expanding on their research approach and actions taken.",
            "ask question": "She is seeking input or opinion from others."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So if you guys because we are very you know I went along the barrier but not the blood brain barrier. So we are applying to learn about. ",
        "annotations": {
            "identify gap": "Judith Eisen indicates a gap in their current knowledge by stating they are 'applying to learn about' a specific area.",
            "clarify goal": "Judith Eisen clarifies her research group's current direction and interests in the context of barriers and the blood-brain barrier."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: First and then some of the more complex systems we couldn't really find the best one. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on their previous statement regarding the systems they are studying or have studied.",
            "identify gap": "The speaker mentions not being able to find the best system for studying more complex systems, which implies identifying a limitation or gap in their research."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I think it's definitely start from both directions approaching to meet out the genetic effect. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas by suggesting an approach to understand the genetic effect.",
            "supportive response": "The speaker expresses agreement with the previous discussion, showing a positive evaluation of the approach being considered."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: And with the molecule needs to be appropriately sized though I mean in a sense if you have there's so many different layers or mediators that are within the blood stream they could impact the endothelium and create leakiness that would be independent of the size of the molecule because once you've broken down the barrier then large molecules can pass too. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by discussing the complexity of the blood-brain barrier and the role of molecule size and mediators in the bloodstream."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: They can but then uh the other question is you know if we're talking about the proper trigger. So sometimes when I sort of think about causation. ",
        "annotations": {
            "develop idea": "He's expanding upon previous discussions by introducing the concept of a 'proper trigger' in causation.",
            "ask question": "Although not a direct question, his statement poses a consideration that could lead to further discussion or clarification."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: So we can really come up with a system where you predict molecular causation because if you do it genetically it's not a lot it's kind of where we don't really have a if you can't predict then you can go by size some of those things will be not specific but others will be. So I don't know that's my thinking. ",
        "annotations": {
            "Develop idea": "The speaker is elaborating on the idea of predicting molecular causation, discussing approaches.",
            "Critical response": "The speaker is providing a critique of genetic approaches in predicting molecular causation.",
            "Offer feedback": "The speaker is providing suggestions or considerations for how to approach the issue of predicting molecular causation."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: To what extent do we actually have to understand those processes for us to even establish causality is the my question for me. So maybe it sort of just depends on the on the type of model we're talking about and. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the necessity of understanding certain processes to establish causality.",
            "None": "No other relevant code applies to this utterance as it primarily functions as a question."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I think it'd be nice, yeah. ",
        "annotations": {
            "Supportive response": "The speaker expresses a positive sentiment or agreement, even though it's minimal, which aligns with the definition of a supportive response."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So I I will I will say for from my own experience I think that can be a big issue especially. So Pamela you work with metabolites and small molecules any any thoughts about this. ",
        "annotations": {
            "ask question": "Judith is asking Pamela for her thoughts on a topic, seeking her expertise.",
            "signal expertise": "Judith is acknowledging Pamela's work and expertise in metabolites and small molecules."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Yeah, so we I mean in the gut we look at barrier with uh you know either two or three cells that you can give the trigger and then measure flux for different sizes. But I'm actually not familiar with the blood brain barrier either. So I'm going to look at that but I imagine it would be similar in terms of if it's a genetic defect how that affects one versus the other barrier and is there a genetic specificity where that will happen. ",
        "annotations": {
            "develop idea": "The speaker is expanding on their previous thought by providing more details about their research and considering its implications for the current discussion.",
            "identify gap": "The speaker identifies their lack of familiarity with the blood brain barrier.",
            "signal expertise": "The speaker is sharing their expertise in certain areas, such as studying barriers in the gut."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I don't know. I'm putting it very complex here but uh but those are probably happening simultaneously or in some individuals one is more uh because the the gut barrier you need like uh integrity and but brain barrier. ",
        "annotations": {
            "develop idea": "She is expanding on previous ideas by discussing the complexity and variability of barrier issues.",
            "express humor": "She lightly suggests she might be overcomplicating things with a casual remark."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I just want to add the comment that so the blood brain barrier the focused ultrasound will cause a temporal gap in the blood brain barrier that allows the passage over kind of subjective and recently in the few human genetics and you can close it again. So so that would allow you at least isolate that barrier separate from the intestinal barrier. ",
        "annotations": {
            "Develop idea": "The speaker is elaborating on existing ideas by sharing specific information about focused ultrasound and its implications for studying the blood-brain barrier.",
            "Offer feedback": "The speaker provides specific information that could be used to modify or enhance understanding of the barriers, particularly in isolating the blood-brain barrier's effects."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: And based on based on those they are able to find some common and and also that the metabolites detected were different and I think that's one step closer to use genetic as defect in the barrier. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas by sharing specific research findings and their implications.",
            "offer feedback": "The speaker provides thoughts on using genetic defects to study barrier functions."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: So I've been thinking about this since last year I would attend this conference. So how how does the gut microbe to the to the you know to the mental disorder is kind of interesting but from you know perspective let's see what's interesting for me. ",
        "annotations": {
            "ask question": "The utterance contains a question about the relationship between gut microbes and mental disorders, seeking information or clarification."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I don't know but I ideally we are able to find genetic variance that is causing for those disease. ",
        "annotations": {
            "clarify goal": "The speaker expresses an ideal goal of finding genetic variance causing diseases.",
            "develop idea": "The speaker builds upon previously discussed ideas about genetics and disease causation."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So with the years there was they they they are a few actually molecules that can relate to these guys and uh you know the specific alleles become very important because some of these molecules are more molecules with our I'd say rather if it's a genetic defect how that affects one versus the other barrier and is there a genetic specificity where that will happen. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by considering the role of specific molecules and alleles in genetic defects and barrier functions.",
            "ask question": "The speaker implicitly asks a question about genetic specificity and its impact on barriers.",
            "clarify goal": "The speaker is clarifying aspects of the goal by discussing relevant factors such as genetic specificity and its impact on barrier functions."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: And so how does that how does that affect one versus the other. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on how a particular factor affects one versus the other."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye -- Georgia: I don't know but I ideally we are able to find genetic variance that is causing for those disease. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno- Oberlin College (she/her): I've been thinking about this since last year I would attend this conference. So how how does the gut microbe to the to the you know to the mental disorder is kind of interesting but from you know perspective let's see what's interesting for me. ",
        "annotations": {
            "ask question": "The speaker is requesting information or discussion on the relationship between gut microbes and mental disorders."
        }
    },
    {
        "utterance": "Lisa Ryno: logical disorder sometimes the important piece of the puzzle isn't the why the causality of it but if you look at this correlation treatment seems to work sort of like what Rosie was presenting with you know those kids having major behavioral improvements. So if I can go back to the metabolites, I know that we we use losing chambers to study just physiology. So I you know, as I'm and to provide and researching fatty acids that would improve just to put the emphasis on can enable causation to in order to demonstrate that. The best one that I know of is IBD so where manipulating the microbiome in that way is a valid form of treatment and just that permeability is one of the other whether that's caused by microbiome changes is unknown at this point or is it simply that permeability is correlated with that. So now we're trying to put together genetics permeability microbiome and I don't think that's resolved right yet. But the other thing that ",
        "annotations": {
            "develop idea": "The speaker expands on existing concepts related to the microbiome, metabolites, and disease, providing more details and examples.",
            "identify gap": "The speaker mentions that the relationship between genetics, permeability, and the microbiome is not resolved yet.",
            "offer feedback": "The speaker provides suggestions and thoughts on how to approach the topic, particularly in demonstrating causation and studying the microbiome's impact."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: I I I feel that one thing she has tried is the approachable relationship from changing microbiome to changing autism behavior. So right now she has open label study but she's moving on to randomized control trial. Although she may not figure out the mechanism but at least with her study she may be able to show that changing microbiome is able to improve the behavior. And in terms of treatment, I think that's good enough for us. We don't need to know the intermediate mechanism. All we know that if we receive that specific microbiome you're able to improve the behavior. I think that's enough for of for our application. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on an idea or approach (the study and its methodology), providing more details and thoughts on its potential effectiveness.",
            "offer feedback": "The speaker provides some suggestions or thoughts on the study approach and its potential, indicating what would be considered sufficient for their application.",
            "supportive response": "The speaker seems to be supporting or validating the approach being discussed, indicating agreement or a positive evaluation."
        }
    },
    {
        "utterance": "Elizabeth Bess: None ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Leah Pyter: too because I mostly start in mice to figure out mechanisms before applying it to humans and she kind of is doing it backwards. Um because yes if you understand the mechanisms maybe you'll be able to hone in on more simple or more palatable of treatments but you know, I think I think even some treatments now are still at the FMT level without having identified, you know, what component of the FMT is actually effective. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of understanding mechanisms before applying treatments to humans, providing reasoning and examples.",
            "offer feedback": "The speaker is providing a perspective on the approach of understanding mechanisms and discussing the effectiveness of certain treatments."
        }
    },
    {
        "utterance": "Mike O'Donnell: What is the host? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about 'the host', indicating a need for further details or understanding within the context of the discussion."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: You're right. ",
        "annotations": {
            "Supportive response": "The utterance 'You're right.' expresses agreement with a previous statement, making it a supportive response."
        }
    },
    {
        "utterance": "Mike O'Donnell: Is it is there something about like ",
        "annotations": {
            "ask question": "The utterance is a clear question, seeking information or clarification on a prior statement or idea proposed by another group member."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: as long as they is is treating humans. the protein or carbohydrate makeup or the ability of those things. ",
        "annotations": {
            "offer feedback": "The speaker provides consideration on the approach by mentioning the importance of protein or carbohydrate makeup or the ability of those things in treating humans.",
            "develop idea": "The speaker is building upon previous discussions by considering the components or functionalities of treatments."
        }
    },
    {
        "utterance": "Mike O'Donnell: Okay. ",
        "annotations": {
            "Supportive response": "The utterance expresses agreement or validation of previous statements."
        }
    },
    {
        "utterance": "Leah Pyter: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So that's ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a very brief acknowledgment without additional content."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: You is it is there something about like ",
        "annotations": {
            "ask question": "The utterance 'Kaixiong (Calvin) Ye: You is it is there something about like ' is a question seeking information or clarification."
        }
    },
    {
        "utterance": "Judith Eisen: Well starting in people is hard, right? And and and maybe should get to a mechanism but you really definitely need a lot of Right, so that could be a possible explanation for what you're seeing. acids we do that for example, right? Um ",
        "annotations": {
            "develop idea": "She is expanding on existing ideas about research approaches and challenges.",
            "clarify goal": "Her discussion relates to clarifying research goals or objectives."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah, I I I think you need a justification to perform a randomized control trial. ",
        "annotations": {
            "offer feedback": "The speaker provides feedback on the necessity of justification for performing a randomized control trial.",
            "develop idea": "The utterance builds upon previous discussions about research methodologies and the importance of justification."
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah. ",
        "annotations": {
            "supportive response": "The utterance 'Yeah.' is a supportive response as it expresses agreement or validation without adding new content."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And to to do that you need evidence that you are closer to which is very important for molecular biology. ",
        "annotations": {
            "develop idea": "The speaker is emphasizing the importance of evidence in molecular biology, building on previous discussions.",
            "supportive response": "The utterance supports the discussion by highlighting the importance of evidence."
        }
    },
    {
        "utterance": "Judith Eisen: to group children into different subgroups? ",
        "annotations": {
            "ask question": "This code applies because Judith Eisen is requesting information or clarification on how to proceed with grouping children.",
            "process management": "This code also applies as grouping children into different subgroups relates to managing the process of organizing a study or discussion."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah, all together we know that you can define them. So so so that's how it's very complicated. So you need to use microbiome to define those sub you know, those two different levels of the tabulation but that may mess up the clinical. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by discussing the complexity of defining subgroups using microbiome data.",
            "offer feedback": "The speaker provides a cautionary note about the potential complications of using microbiome data to define subgroups."
        }
    },
    {
        "utterance": "Leah Pyter: Sorry. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: I'm going to say that the internet kicks me out and took me a lot of you able to get back in. So I hope you guys were doing great without your moderator. But I do teach about some of this stuff. So from what I've read, my understanding is that you know, it's it's at least in this country, it's a lot of the behavioral criteria and there's a way that people are evaluated by those behavioral criteria. ",
        "annotations": {
            "signal expertise": "The speaker mentions her teaching experience related to the topic of discussion.",
            "None": "No relevant code applies to the majority of the utterance as it's primarily about reconnecting."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Oh I was just going to bring up a more direct interaction. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is too brief and does not explicitly engage with the discussion in a way that would categorize it under the provided codes."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So basically right now we can use those have similar effect increase permeability. So so so that's how it's very complicated. So you need to have at least three screen in the class. There's perhaps for primary subject time if you go to level then you can we we focus on one aspect for that otherwise it's very hard to address all of them. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas through reasoning and discussion of the complexity of their research and potential approaches."
        }
    },
    {
        "utterance": "Judith Eisen: That's a good point though. Um so it sounds although going back to the original question, it sounds plausible that certain microbes um either make small metabolites that are barrier or or that's not a protease. Um so so that was something very surprising. So those also can get involved but I'm not sure at what level because there are two ways of at least two ways, right? might be can be directly through tight junction effects. ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas by suggesting that certain microbes could produce small metabolites affecting barriers and mentioning the possibility of direct effects through tight junction effects.",
            "acknowledge contribution": "The speaker acknowledges a previous point made ('That's a good point though')."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: I'm actually curious when when when when the team members here first chose this topic. I think one one of those is that in microbiome there was a lot of correlation specific microbes competition is associated with a specific disease. You have even diet and the microbiome there's a lot of correlation. And I think there's there's a you know, big one is that the motivation can can is good at those microbes and microbial that was my my motivation. ",
        "annotations": {
            "ask question": "The speaker is asking about how the team members chose their topic."
        }
    },
    {
        "utterance": "Elizabeth Bess: The immune cells serve as a ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So it sounds plausible that certain microbes um either make small metabolites that ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by suggesting that certain microbes could produce small metabolites that might have an effect."
        }
    },
    {
        "utterance": "Judith Eisen: And from there we wanted to see how we were seeing coordination and reach among the most fine grained aspects and that's where actually all those strains was a lot of so a lot of strange things could be by their ability to damage more so there's still a lot of published so how do you to power what is the reason and that's why we were able to ",
        "annotations": {
            "Summarize conversation": "The speaker is reflecting on previous research or discussion points, indicating a summary of conversation.",
            "Ask question": "The speaker is seeking clarification or understanding on a specific aspect of the research, evident from the questioning tone."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: And then outside the microbiome I feel that we found actually the chance for mechanistic insight is very very high and so so anyway and that toxin is actually released and it correlates with you can add those functions that have severe disease in mice and see how those strains that produce the toxin so so it's it's minimal but have like able to mimic that or manipulate I'm looking always for ways to actually do the screening but I mean that's the major chair if you mess up if you screw any output then you actually like a research that you're driving a lot of information understanding and you lose something that might be actually there. ",
        "annotations": {
            "clarify goal": "The speaker discusses the goal of achieving mechanistic insights, which is a key aspect of their discussion."
        }
    },
    {
        "utterance": "Judith Eisen: Because most of the I mean um it's always a constant microbial genetics ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it seems to be a continuation of thought or discussion without clear introduction of new ideas, questions, or explicit actions that fit into the provided categories."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: to discover Aaron's comment on the the link via the immune system kind of brought something to mind there's been some increased interest lately in terms of the inflammatory response originating from from ",
        "annotations": {
            "develop idea": "Judith Eisen is expanding on a thought triggered by Aaron's comment, building upon his idea to introduce another related aspect.",
            "None": "No other codes seem to directly apply besides 'develop idea'."
        }
    },
    {
        "utterance": "Andrew Feig: I will say ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: I'd really look at stroke models more closely if not just working on the microbiome it looks seems like a a large portion of those immune cells are coming from from the from the microbes we don't have necessary genetic tools to ",
        "annotations": {
            "propose new idea": "The speaker suggests a new research approach by recommending to look at stroke models more closely in the context of the microbiome and immune cells.",
            "develop idea": "The speaker builds upon existing knowledge about the relationship between the microbiome, immune cells, and disease, suggesting a specific model (stroke models) to study this relationship."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: So it's very ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: something that is very open to potential either metabolites or to toxins things like that coming from from the gut and there's just some really interesting observations ",
        "annotations": {
            "develop idea": "The speaker is expanding on previous ideas about the gut microbiome and its products, suggesting a direction for further investigation.",
            "supportive response": "The tone of the utterance is positive towards exploring the potential of metabolites or toxins from the gut."
        }
    },
    {
        "utterance": "Andrew Feig: I'll just chime in just a second you know about regulation of IGA in the gut 12 years ago I saw the first study increase IGA production it was an animal based study the ability to impose kind of this coevolutionary idea that shifts to the benefit of the organism so if something gets across the epithelium to also be able to recognize that at the level so you could actually do respond very rapidly whether that's and plasma cells which are in the gut and the ability to add to the through a manipulation to have pretty free access to what was really astounding granted that was the antigen there that's very interesting I I looked at those what's the antigen to bring that to activate the plasma cell to express IGA or it's passing through genetic manipulation on a metabolite that's in the gut ",
        "annotations": {
            "signal expertise": "The speaker explicitly states his experience and knowledge about the regulation of IGA in the gut.",
            "develop idea": "The speaker expands on his idea by discussing the coevolutionary concept and its implications for rapid response.",
            "ask question": "The speaker asks a question about the antigen that activates plasma cells to express IGA."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Andrew Feig: there's circulation now and on the Venus side that's where it's highly concentrated so you can have the ability to the gut and bring it up to the brain and that's where it's highly concentrated so you can have the ability to do some of the causal studies in the case of stroke at least in animals that would be a little harder to get approved in humans as well ",
        "annotations": {
            "develop idea": "The speaker is expanding on a concept related to the circulation of substances from the gut to the brain and their implications for causal studies in stroke, building upon existing ideas or context."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Yeah so the migration of IGA plasma from the gut going far away it's very hard to track ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the concept of IGA plasma cell migration from the gut.",
            "identify gap": "The speaker mentions that it is very hard to track the migration of IGA plasma cells, indicating a gap in knowledge or methodology."
        }
    },
    {
        "utterance": "Judith Eisen: I going back to to the point that you need to limit the work actually to the gut because because IGA plasma are you know just America genetic tools if you have antigen more much more ",
        "annotations": {
            "develop idea": "The utterance expands on a previous point about focusing on the gut.",
            "identify gap": "The utterance hints at a limitation or specific condition related to IGA plasma and genetic tools.",
            "process management": "The utterance refocuses the discussion on studying the gut."
        }
    },
    {
        "utterance": "Lisa Ryno: I was just going to say you know I think one model that is overlooked a lot one of my colleagues at University is doing for larger scale because it does have a brain access as rudimentary as it is ",
        "annotations": {
            "propose new idea": "The speaker introduces a new idea about a model that is overlooked.",
            "identify gap": "She points out that a model her colleague is working on is overlooked a lot.",
            "develop idea": "She starts to elaborate on this idea, though briefly."
        }
    },
    {
        "utterance": "Leah Pyter: I wondered too if we're focused on ",
        "annotations": {
            "ask question": "The speaker is seeking clarification or information about the focus of the discussion."
        }
    },
    {
        "utterance": "Judith Eisen: I just think that's another big area of host resident microbes make just huge numbers of metabolites including pretty much all the neurotransmitters you can think of so it seems very unlikely that those neurotransmitters are going to go across the gut to the brain in the sort of quantities that you need to activate synapses but they can certainly change the overall humoral ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by discussing the role of host resident microbes in producing metabolites and neurotransmitters and their potential impact on the brain."
        }
    },
    {
        "utterance": "Leah Pyter: So I really like that immune pathway and really focus a lot on that because ",
        "annotations": {
            "supportive response": "Leah is expressing a positive sentiment towards the immune pathway, indicating agreement or support."
        }
    },
    {
        "utterance": "Judith Eisen: Like even lower than the organic level is like what's the composition how do how do those signals get to the brain ",
        "annotations": {
            "ask question": "The speaker is requesting information about the composition and how signals get to the brain, seeking clarification on a specific topic."
        }
    },
    {
        "utterance": "Lisa Ryno: Yeah ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: the gut has its own enteric nervous system I'm just kind of spitting out what I'm just thinking about is that the models that involve you know soluble or insoluble ",
        "annotations": {
            "develop idea": "Judith Eisen is expanding on her thoughts regarding the enteric nervous system of the gut and its possible implications for models involving soluble or insoluble factors.",
            "None": "No other codes seem to directly apply based on the provided definitions and the content of the utterance."
        }
    },
    {
        "utterance": "Lisa Ryno: I was just going to say you know I think one model that is overlooked a lot one of my colleagues at University is doing for larger scale because it does have a brain access as rudimentary as it is I guess sort of thinking about those unculturable microbes but perhaps identifying like Calvin mentions some mechanistic or more metabolites related secreted maybe the secreted proteins things that could then be back engineered into more genetically manipulable organism to help establish those ",
        "annotations": {
            "propose new idea": "Lisa Ryno introduces a new model or approach for studying the gut-brain axis, suggesting the use of unculturable microbes or their metabolites.",
            "develop idea": "She expands on this idea by suggesting that these microbes or their products could be used to establish connections between the gut microbiome and brain-related phenomena."
        }
    },
    {
        "utterance": "Leah Pyter: I wondered too if we're focused on like plasma metabolites if we're overlooking really localized metabolites that are actually signaling to the brain neural metabolites to mention that has tons of iron transporters that that would be great if you could find that because it sucks up all of the iron ",
        "annotations": {
            "propose new idea": "The speaker introduces a perspective on potentially overlooked aspects of metabolites (localized vs. plasma) that could be relevant to the discussion.",
            "develop idea": "The speaker builds upon the existing discussion by suggesting an additional area of focus (localized metabolites).",
            "ask question": "The speaker poses a question indirectly by suggesting an area of investigation: whether focusing on plasma metabolites overlooks the effects of localized metabolites."
        }
    },
    {
        "utterance": "Judith Eisen: Well that's I just think that's another big area of host resident microbes make just huge numbers of metabolites including pretty much all the neurotransmitters you can think of so it seems very unlikely that those neurotransmitters are going to go across the gut to the brain ",
        "annotations": {
            "develop idea": "The speaker is expanding on the concept of microbes producing metabolites and neurotransmitters.",
            "offer feedback": "The speaker is providing a perspective on the feasibility of neurotransmitters crossing the gut-brain barrier."
        }
    },
    {
        "utterance": "Andrew Feig: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it only contains a minimal acknowledgment ('Yeah') without additional content that could be coded based on the provided categories."
        }
    },
    {
        "utterance": "Judith Eisen: Like even lower than the organic level is like what's the iron composition how do how do those signals get to the brain ",
        "annotations": {
            "ask question": "The speaker is requesting information on the iron composition and how signals get to the brain, seeking clarification on the mechanisms involved."
        }
    },
    {
        "utterance": "Andrew Feig: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So there's direct signaling from the gut to the brain the gut has its own enteric nervous system communicated by the vagus probably also by the enteric nervous system ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by providing more details about the gut-brain connection, specifically highlighting the role of the enteric nervous system."
        }
    },
    {
        "utterance": "Kaixiong (Calvin) Ye: Oh ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So there could be neural roots particularly for the for expert there could be immune roots that things could travel so are you are you all to iron or to other inorganic molecules ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas by suggesting neural and immune roots as pathways.",
            "ask question": "The speaker ends with a question about iron or other inorganic molecules.",
            "encourage participation": "The speaker invites response with a question."
        }
    },
    {
        "utterance": "Andrew Feig: Yeah ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Leah Pyter OSU (she/her): Yeah, I find that one more feasible than like changes in rate or high enough concentration when it gets up to the brain to you know, change behavior. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation of a previously mentioned idea or perspective on the feasibility of certain mechanisms affecting the brain and behavior."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: To think about if we could go back to Farouk's question like what would be a model system to figure out what seems feasible in the process and how bacteria what doesn't seem so feasible and how we could impact um just barrier function in general. ",
        "annotations": {
            "Ask question": "The speaker is seeking information about what would be a model system to understand feasibility.",
            "Develop idea": "The speaker is expanding on a previous question to suggest a way to explore the topic further."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I'll use neurobiologist to get back to the warmth of this you could also do it with supernate and we've tried to fractionate the supernate and metabolites. ",
        "annotations": {
            "offer feedback": "The speaker is providing a suggestion for an approach, offering a method that has been tried.",
            "develop idea": "The speaker is elaborating on a possible method, building upon the existing discussion."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: But but working with the system you know I sort of reecho this this seems like an iterative screening process where you have a model system and iteratively just screen and focus on a just general phenotype. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on a research approach by suggesting an iterative screening process.",
            "supportive response": "The speaker is expressing agreement with the approach being discussed.",
            "offer feedback": "The speaker is providing a suggestion for how to proceed with the research."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: So hence the idea of something like the silog where people who come from all different areas of science get together and think about questions or like that might be a mutual interest that they could approach from a lot of different directions. ",
        "annotations": {
            "process management": "The speaker is suggesting a method for organizing research collaboration by bringing together people from different areas of science.",
            "encourage participation": "The speaker is encouraging participation from individuals with different scientific backgrounds by suggesting they work together on mutual interests."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: I think that's a great question my lab's been starting to do C elegance work and that's a source of inspiration for like screening the work and like figuring it out but it's not as I have any comments thoughts um some things that we've come across working with C elegance is that it's it's it's diverse we can make mutants in low oxygen environments but how might that trigger the production of mucus. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on their experience with C. elegans, explaining its diversity and potential applications.",
            "ask question": "The speaker asks a question about how certain conditions might trigger the production of mucus.",
            "signal expertise": "The speaker mentions their lab's experience and work with C. elegans, indicating their expertise in this area."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I see so is this the is this the E letter so so is this uh we still try to figure out how to utilize that. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about 'the E letter' and its utilization."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Um that's also a source where they're they're doing their research but for the mucus that triggers also mucus activation that's something that's that could be done there too. ",
        "annotations": {
            "offer feedback": "Providing a suggestion for a research direction.",
            "develop idea": "Expanding on existing ideas by suggesting a potential research area."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I really like the studies from uh Gunar's lab so the so yeah I guess I don't I haven't worked up much with hypoxia in my case but but is there a challenge there of getting worms to survive in Gunar's hypoxic conditions or. ",
        "annotations": {
            "ask question": "The speaker is requesting information about challenges in Gunar's lab regarding worm survival in hypoxic conditions."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Um I think I went to one meeting that was very boring and that told shine and very important and other told. ",
        "annotations": {
            "express humor": "The speaker makes a joke about attending a boring meeting, attempting to inject humor into the conversation."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: Yeah, so I I mean I'm I'm exclusively working with mucosal so so you know it's it's it's it's definitely a challenge. ",
        "annotations": {
            "signal expertise": "The speaker explicitly states his own expertise or area of work, mentioning that he is exclusively working with mucosal."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: So if you're interested I can send you some. ",
        "annotations": {
            "Supportive response": "The speaker is offering to share information or resources, which is a positive and supportive action."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: That's that's really low oxygen so but for humans it's kind of very tricky and I've thought about it about two to three years ago. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: So I was a PhD student in Carolyn's lab that was part of my. ",
        "annotations": {
            "signal expertise": "The speaker is explicitly stating her own background as a PhD student in Carolyn's lab, which can be seen as signaling her expertise or qualifications."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: Right so so basically all the PhD I don't I don't have a good solution for that and so they are clean if you're talking about sort of lower oxygen conditions you can actually go against the wall but there are sort of there's a reason that you can use that that's where we did the sequence and that's how we found what's associated with the cause but in humans it's very hard otherwise if you go with the pro you know in the sample cleaning across the board goes after that material but in mice you can do a lot of that's that's low oxygen. ",
        "annotations": {
            "develop idea": "Elaborating on existing ideas or methods, specifically discussing approaches to low oxygen conditions and sample cleaning.",
            "identify gap": "Highlighting a gap in knowledge or method between humans and mice studies.",
            "offer feedback": "Providing feedback on the feasibility and challenges of different research approaches."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Well to your less specific question it's more black and white you know in our in our first blush attempts to understand something we kind of overlook the nuances you know what the nuances are and then as you start to to get down into it more you discover so do you know that there are groups so if you have a particular group for example an O that would be a substrate for a even though we know that there are things that are maybe in the context of a gut and the are so the which are maybe they're surrounded by other guys that are modulating the environment for those bacteria that are utilizing these things like breaking it down. ",
        "annotations": {
            "develop idea": "The speaker is elaborating on the nuances of scientific research, specifically discussing how initial attempts to understand complex systems like gut bacteria may overlook nuances that become apparent with further research."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: So this is sort of maybe maybe this is sort of a big picture question that I have so so for broader identification of those things that are that are able to perform these mucal. ",
        "annotations": {
            "ask question": "The speaker is seeking broader identification of certain phenomena, posing a question to the group."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: It's very hard yeah yeah yeah but that's the that's the dream actually to do it. ",
        "annotations": {
            "supportive response": "The speaker expresses a positive sentiment and encouragement towards achieving a difficult goal."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Sorry, so I was a PhD student in Carolyn's lab. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: So we have about another 15 minutes and then it might be a good idea to ",
        "annotations": {
            "process management": "The speaker is mentioning the time constraint and suggesting a potential next step, which is managing the meeting flow."
        }
    },
    {
        "utterance": "Judith Eisen: Elizabeth, you're you're cutting off, would you share her screen so we can summarize highlights and see what we're going to report. ",
        "annotations": {
            "process management": "Judith Eisen is managing the meeting flow by asking Elizabeth to share her screen.",
            "assign task": "Judith Eisen assigns the task of sharing her screen to Elizabeth.",
            "summarize conversation": "Judith Eisen wants to summarize highlights and discuss what they will report."
        }
    },
    {
        "utterance": "Elizabeth Bess: Um so I'm I'm I'm happy to let you know in like 10 or 15 minutes, but I just wanted to bring to your attention that maybe ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by indicating when she will share information."
        }
    },
    {
        "utterance": "Judith Eisen: Oh, and another one. Um if there's something you really wanted to say and you haven't brought it up, maybe this is a good time. ",
        "annotations": {
            "final answer": {
                "encourage participation": "The speaker invites others to contribute their thoughts or comments if they haven't already done so."
            }
        }
    },
    {
        "utterance": "Judith Eisen: I I think these are all really important points. Any other thoughts that you have maybe before we start editing the discussion? I mean, my experiences from zebrafish. I know specific cause, but I do I'm not trying to suggest that it's the be all and all in any way, but one thing that we can do is we can we can watch things and we can at least in some cases if you have how's your molecule with the right floor for or your bugs with the right floor for or cells with the right floor for for all of those things, you can actually um try to find out some of the interactions that are going on at least in the in the larvae. Um ",
        "annotations": {
            "encourage participation": "The speaker invites others to contribute their thoughts.",
            "develop idea": "The speaker develops an idea by sharing her experience with zebrafish."
        }
    },
    {
        "utterance": "Judith Eisen: Um so it's they're really powerful but they're very low throughput. ",
        "annotations": {
            "critical response": "Judith Eisen is questioning the feasibility or practicality of a method by mentioning it is 'very low throughput'.",
            "offer feedback": "Judith Eisen is providing feedback on the method by highlighting its limitation of being 'very low throughput'."
        }
    },
    {
        "utterance": "Lisa Ryno: I think it definitely goes back to what we can put organize your data about it sort of being a bidirectional process where you know we're can start start at the most reductionist molecular mechanism and that will inform higher order higher complexity experiments and then on the other end you can look at behaviors and whatever disease model you're studying and then you can go backwards from there too. ",
        "annotations": {
            "develop idea": "The utterance expands on an idea of how to approach studying complex biological processes by suggesting a bidirectional process."
        }
    },
    {
        "utterance": "Lisa Ryno: It seems like in order to have a holistic picture, you have to cover all of the bases before you set it up. So the only thing we can do is potentially for tissues from ",
        "annotations": {
            "summarize conversation": "The speaker is reflecting on the conversation to emphasize the importance of a comprehensive approach.",
            "offer feedback": "The utterance provides a suggestion for approaching their scientific inquiry."
        }
    },
    {
        "utterance": "Judith Eisen: I think we've we've made a lot of points and ",
        "annotations": {
            "Summarize conversation": "The speaker is summarizing that many points have been made in the discussion."
        }
    },
    {
        "utterance": "Leah Pyter: I think even making that jump from like a germ free organism to a conventional organism that already has an ecosystem um and that you might need to use like a pre treatment like an antibiotic to really even make any sort of difference is just a hugely useful and it may not look anything like what you found in your original ways for relating that with barrier integrity to then first cast a wide net and then narrow things down for these. ",
        "annotations": {
            "identify gap": "The speaker recognizes the complexity and potential gap in knowledge when moving from germ-free to conventional organisms.",
            "offer feedback": "The speaker provides a suggestion for experimental design (using antibiotics as a pre-treatment)."
        }
    },
    {
        "utterance": "Judith Eisen: Yeah, we don't really make germ free people, although the bank of mice is is is is is I mean that's maybe as close as one gets. I mean really reliable. So ",
        "annotations": {
            "clarify goal": "The speaker discusses the use of germ-free mice as a reliable model when studying in a context that cannot be done with humans, clarifying the goal of using such models."
        }
    },
    {
        "utterance": "Judith Eisen: I think there's more a lot of movement towards co culture systems with more engineering involved where you have small wells that are separating cells um to kind of create gut brain models that way. So I that's not something that I know much about, but that's certainly where people are going with um collaborating with engineers and think that. ",
        "annotations": {
            "process management": "Discussing a methodological approach to research involving co-culture systems and engineering.",
            "supportive response": "Expressing a positive view on the trend of collaborating with engineers for research."
        }
    },
    {
        "utterance": "Mike O'Donnell: I have about two pages of notes so I can figure out how to distill this down to a few sentences. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Richard, this session's over at 11:50, is that right? ",
        "annotations": {
            "process management": "Verifying the end time of the session with Richard to manage the meeting flow."
        }
    },
    {
        "utterance": "Richard Wiener: Yes, I think you still have a little bit of time to to to go to another topic maybe about 11:40 you would start to kind of summarize let Mike try to to uh down a couple big points. ",
        "annotations": {
            "process management": "Managing the meeting flow by discussing time and summarization of discussion points."
        }
    },
    {
        "utterance": "Judith Eisen: I I think we've we've made a lot of points and ",
        "annotations": {
            "summarize conversation": "The speaker is summarizing the points made during the discussion."
        }
    },
    {
        "utterance": "Elizabeth Bess: Okay, I'm just going to direct my voice right into my microphone. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: Um so I I'm wondering um you know I I there are sensors that I have been seeing that can be implanted in the brain for measuring like ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about sensors that can be implanted in the brain for measurement purposes."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Hi, I I have been I was listening and um you know, mainly because my expertise is not really in biology side. I'm a device person and a person who develops biosensors. So basically tools for measurement but not optical. So electronic, electrochemical sensors, um nano devices, a small, you know, sensors basically. And you know, we have been working on, you know, we work on small molecules from or or RNS and neurochemicals and also to more pathogen bacteria. Uh we have been looking at its antibiotic response using these sensors as we basically develop. So we use a lot of nanotechnology, nano materials, ",
        "annotations": {
            "signal expertise": "The speaker explicitly states her own expertise and qualifications related to biosensors and nanotechnology.",
            "acknowledge contribution": "The speaker contributes to the discussion by introducing her background and work."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Um what are your you know, wish list for example, like in these individual topics that you mentioned, you know, what are ",
        "annotations": {
            "ask question": "The speaker is requesting information about others' wish lists regarding the topics mentioned."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Uh looks like sensors, sorry, you know, my lack of knowledge in this area, but um what do you like to or what what would be beyond the traditional standard for characterization. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification.",
            "identify gap": "The speaker mentions her lack of knowledge in the area."
        }
    },
    {
        "utterance": "Elizabeth Bess: There are sensors that I have been seeing that can be implanted in the brain for measuring like neurotransmitter production etc. being able to measure and talk about if they're really correlated that undergo enterohepatic recycling or produced in the GI tract even if it's small. There was a fair amount of discussion about the various pieces of things that could be impactful and direct versus indirect effects. So ",
        "annotations": {
            "signal expertise": "Elizabeth Bess shares her knowledge about sensors, signaling her expertise in the area.",
            "develop idea": "She expands on the discussion by mentioning specific tools (sensors) that could be used for measuring neurotransmitter production.",
            "supportive response": "The utterance is supportive as it contributes to the discussion and offers potential solutions."
        }
    },
    {
        "utterance": "Elizabeth Bess: Okay, I'm ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: That's really uh you know, that that's a great you know, point that you mentioned. So it's really like a uh very big wish um dream I would say there are a lot of ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges a previous point made by others.",
            "supportive response": "The speaker expresses agreement and a positive evaluation of the previous point."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Like you may have heard about like smart capsule or smart pills. Uh there has been it it has been like you know, going around for a long time really like a dream that people want to have something ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: And then it can monitor and screen uh not just collect not just collect because there are capsules that you know you can eat them then um the prototype is uh they are going to uh capture uh like bacteria for example into a small polymer based capsule with hydrogel and stuff then when it is excreted by body, you know, you can take it out and then do the analysis, you know? ",
        "annotations": {
            "signal expertise": "The speaker explicitly states their background and work related to biosensors and nano devices.",
            "develop idea": "The speaker is elaborating on the concept of smart capsules or pills, providing details about their functionality and potential applications."
        }
    },
    {
        "utterance": "Aida Ebrahimi: I'm talking about something else like real time as you mentioned like real time something that goes through and then it scans for different uh ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previously mentioned concept of real-time scanning or measurement."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: I I agree with Elizabeth. ",
        "annotations": {
            "Supportive response": "Judith Eisen is expressing agreement with Elizabeth's contribution, which serves as a positive evaluation.",
            "Acknowledge contribution": "Judith Eisen is also verbally recognizing Elizabeth's input."
        }
    },
    {
        "utterance": "Judith Eisen: I think this would be a game changer. ",
        "annotations": {
            "supportive response": "Judith Eisen expresses a positive evaluation of the idea discussed, indicating it could be a game changer."
        }
    },
    {
        "utterance": "Judith Eisen: is about to have real time monitoring of the brain or whatever else it is that you want to monitor. I mean and you can imagine, I mean my dream, we talked about it in that earlier icebreaker session is that you can you can monitor all the different things you want to monitor at once. Of course that's probably being really greedy and you know we have to back off a little bit. But even the case that you brought up Elizabeth of a metabolite, if you could monitor that metabolite and who's who's eating it and what they're turning it into, so the life of that metabolite in the gut as it does whatever else it does in the body that would be something in the brain would be amazing. ",
        "annotations": {
            "develop idea": "Judith Eisen expands on the concept of real-time monitoring and its applications.",
            "acknowledge contribution": "She references and builds upon Elizabeth's idea about metabolites.",
            "clarify goal": "Judith Eisen discusses the goal of utilizing monitoring technology for deeper understanding of biological processes."
        }
    },
    {
        "utterance": "Judith Eisen: And then if you start thinking about causation versus correlation, it really starts to get you to the biochemistry of of those processes and then you have you know actual biochemical testing that you could do to to ask whether your inferences are are correct and whether if you play with this thing in some particular way, you can change a different process. ",
        "annotations": {
            "develop idea": "The speaker is expanding on existing ideas about moving from correlation to causation in understanding biological processes.",
            "offer feedback": "The speaker provides a suggestion for approaching the problem through biochemical testing.",
            "clarify goal": "The speaker is contributing to defining the goal of understanding biological processes at a deeper level."
        }
    },
    {
        "utterance": "Judith Eisen: That would be amazing. Figure out if I'm missing something or if there's better ways to do it. Aida make these for us. ",
        "annotations": {
            "assign task": "The speaker, Judith Eisen, directly assigns a task to Aida, requesting them to develop or provide something.",
            "supportive response": "The utterance expresses a positive evaluation of an idea and seeks better ways to achieve it, showing support."
        }
    },
    {
        "utterance": "Aida Ebrahimi: I have another question like, what is the correlation between gut microbiome and like oral cavity microbiome like mouth microbiome? What is the correlation? The reason I'm asking it is because screening like saliva for example or breath it's it's easier to actually going down in the in the gut, you know? So I was wondering is there any study or like solid evidence or not even that solid, I don't know what the word is between correlation of gut and like you know the microbiome that we have for example or similarly microbiome in our mouth and brain. ",
        "annotations": {
            "ask question": "Aida Ebrahimi is requesting information on the correlation between gut microbiome and oral cavity microbiome, seeking existing studies or evidence."
        }
    },
    {
        "utterance": "Judith Eisen: So there's been there's been work on this. So the human microbiome project um looked at the oral microbiome, the gut microbiome, the genital microbiome, the skin microbiome. I think they were seven different places. I don't remember what they all are. And you're right there's there's actual published data on the stuff in your mouth is linearly proportional. There are some lower throughput methods that might be useful for aerobic and anaerobic stuff to test specific hypothesis, but we need to get there. We need to know which specific hypothesis that we want to be testing on. ",
        "annotations": {
            "develop idea": "The speaker expands on previous discussion by providing information about the human microbiome project's work on various microbiomes.",
            "signal expertise": "Judith Eisen demonstrates her knowledge of the human microbiome project and its scope.",
            "identify gap": "The speaker highlights the need for specific hypotheses to test, indicating a gap in current knowledge."
        }
    },
    {
        "utterance": "Judith Eisen: What do you guys think? So and there's a lot of differences which is not to say that there aren't some commonalities. Feel free to correct that or add something else. I'm just trying to get other people help bearing. The point that you brought up about microbiome is an interesting one because the brain is thought to be sterile, no bugs in there unless you get a breach of the blood brain barrier. ",
        "annotations": {
            "encourage participation": "Judith invites others to contribute their thoughts, correct her, or add to the discussion, directly encouraging participation."
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah, I have it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Okay, thanks. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: about four or five years ago there was a paper that was published where at the EM level somebody saw bacteria. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: I know I know someone at ASU that got that last year by the way. ",
        "annotations": {
            "signal expertise": "The speaker is referencing her connection to someone at ASU who has made a relevant discovery, thereby signaling her own expertise or knowledge in the field."
        }
    },
    {
        "utterance": "Judith Eisen: Oh really? What we want to say. There was a study that made it clear that wash at the EM level somebody saw bacteria. So I'm trying to look for follow up work. There's been enough in that time. ",
        "annotations": {
            "clarify goal": "Judith Eisen is seeking more information about a study and its follow-up work, indicating a desire to clarify the goals or objectives of the research in that area."
        }
    },
    {
        "utterance": "Mike O'Donnell: Do you think that okay so if you go to NIH with this idea and if you're talking about high throughput high throughput screens immediately the reviewer says this is fishing expedition, this is hypothesis generating. ",
        "annotations": {
            "ask question": "The speaker is seeking thoughts or opinions on the challenge of presenting high-throughput screen ideas to NIH.",
            "process management": "The utterance discusses navigating the research funding process and potential criticisms from reviewers."
        }
    },
    {
        "utterance": "Judith Eisen: certainly there are cases where people you know have has not been convinced that the gut microbiome is involved. ",
        "annotations": {
            "None": "No relevant code directly applies to this utterance as it primarily serves to acknowledge a perspective without adding new content or fitting neatly into another category."
        }
    },
    {
        "utterance": "Mike O'Donnell: Can you do that? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on whether something can be done."
        }
    },
    {
        "utterance": "Mike O'Donnell: Uh yeah, I have it. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Aida Ebrahimi: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: So so those are the mechanisms here, yeah. One one comment that I want to make especially to junior faculty is that not funded by NIH does not mean that it's not good research and it doesn't mean that it's not promising research indeed. And NIH chose not to fund um the production of insulin through genetic engineering the way it's done. ",
        "annotations": {
            "offer feedback": "Provide specific suggestions for improvement or sharing insights based on experience."
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Oh yes, there we go. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or confirmation, indicating a positive or supportive stance towards the previous statement or situation."
        }
    },
    {
        "utterance": "Mike O'Donnell: I'll just blow that's really small. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: Anyway, so so those are the mechanisms here, yeah. And one one comment that I want to make especially to junior faculty is that not funded by NIH does not mean that it's not good research and it doesn't mean that it's not promising research indeed. ",
        "annotations": {
            "Supportive response": "The speaker is offering encouragement to junior faculty.",
            "Offer feedback": "The speaker is providing advice on how to perceive research funding."
        }
    },
    {
        "utterance": "Aida Ebrahimi: That was a great point. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement or validation with a previous contribution, without adding new content."
        }
    },
    {
        "utterance": "Mike O'Donnell: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: It does. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: You're welcome. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and a positive sentiment, which is a supportive response to a prior interaction."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: You're welcome. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: So I I confess I wasn't invited to be part of the U panel last year but I wasn't so I wish I had been there so I could give you an answer of like what the panel was actually looking for. We didn't get a lot of feedback either so that's but but you know those are kind of pain questions that you can provide that on your surveys as a community that might be helpful to get some feedback on your proposals. ",
        "annotations": {
            "acknowledge contribution": "Judith Eisen acknowledges the lack of feedback received.",
            "offer feedback": "Judith Eisen offers a suggestion for improving feedback through surveys.",
            "process management": "Judith Eisen suggests using surveys as a community tool for gathering feedback on proposals."
        }
    },
    {
        "utterance": "Mike O'Donnell: I guess I have a question. ",
        "annotations": {
            "ask question": "The speaker explicitly states they have a question, indicating a request for information."
        }
    },
    {
        "utterance": "Judith Eisen: I mean aside from Sialog. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell: So I guess what I'm asking is that if you know it's a good idea, pursue it through other ways or pursue getting preliminary data so you can show that when I each that's that's my advice here, you know, my mentoring advice. ",
        "annotations": {
            "offer feedback": "Provides specific suggestions for improvement.",
            "signal expertise": "Shares experience or expertise through mentoring advice."
        }
    },
    {
        "utterance": "Aida Ebrahimi: Are there other. ",
        "annotations": {
            "ask question": "The speaker is requesting information about the existence of other methods, tools, or approaches beyond what has been discussed."
        }
    },
    {
        "utterance": "Lisa Ryno: Sorry, this is getting off topic. ",
        "annotations": {
            "process management": "The speaker is managing the conversation flow by suggesting that the discussion is getting off topic."
        }
    },
    {
        "utterance": "Judith Eisen: But other other places that would be in pretty good categories. So I guess we should add more details if we want to, but what do other people think? ",
        "annotations": {
            "ask question": "The speaker explicitly requests the opinions of others, seeking their thoughts or input on the matter."
        }
    },
    {
        "utterance": "Elizabeth Bess: Come up. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: Is is that a. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess: Yeah, absolutely. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement.",
            "acknowledge contribution": "The speaker is verbally recognizing a previous statement."
        }
    },
    {
        "utterance": "Mike O'Donnell: That wasn't a derisive laugh that was. ",
        "annotations": {
            "offer feedback": "The speaker is providing a clarification or mild correction regarding the nature of a laugh."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement or validation for other group members' contributions without adding new content."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement with a prior statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement, showing support and confirmation without adding new content."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a prior statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The utterance 'Exactly. ' expresses agreement with a previous statement, validating or supporting the idea or statement made."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement with a prior statement."
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen: Exactly. ",
        "annotations": {
            "Supportive Response": "The speaker is expressing agreement with a previous statement."
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: You're absolutely right and I feel that and the co professor, I don't know that is the right professor. Like I agree with this, you know. ",
        "annotations": {
            "supportive response": "Expressing agreement, validation, or positive evaluation for other group members' contributions without adding new content."
        }
    },
    {
        "utterance": "Leah Pyter, OSU (she/her): May I agree with what you're saying is what you're saying encapsulates microbial non microbial. I mean the institution I'm right now they are very supportive to that one. I think that's a fair I was in another institution and I wrote a grant that was like 5% and they were like 45% to pay to the institution. Yeah, so it depends on the institution. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement with previous statements and shares a personal experience, showing support and validation for the discussion.",
            "None": "No other codes explicitly apply to this utterance as it does not introduce new ideas, ask questions, signal expertise, identify gaps, or engage in other coded behaviors."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I always like to think about these things foundations are really good and if you guys can get something from the social dialogue that might so you know you wanted to over expression and you want to do knock out. You want to move something and meeting people who do that something you want to remove something people on my end of the channel does the opposite of what I'm. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Hey guys happy with her report. ",
        "annotations": {
            "ask question": "Requesting information or feedback about the group's satisfaction with the report."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: You know what you've moved. Sorry Aaron. ",
        "annotations": {
            "acknowledge contribution": "Judith Eisen verbally recognizes Aaron's input.",
            "supportive response": "Judith Eisen expresses empathy or understanding towards Aaron."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: Yeah amazing. Thanks a lot for doing that. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes someone's input and expresses thanks.",
            "supportive response": "The speaker expresses a positive evaluation of the previous discussion or outcome."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Let's go back to that for two minutes to make sure this isn't just making stuff up. ",
        "annotations": {
            "process management": "The speaker is managing the meeting flow by suggesting a revisit of a previous topic to ensure accuracy.",
            "ask question": "The speaker is also implicitly asking for clarification or verification of previous discussion points."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Microbial metabolites, but there are epithelial cell metabolites, but there's got to be cell metabolites. Can you pull back the can then can then move directly or you want you want it there. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the concept of different types of metabolites and their potential interactions or manipulations.",
            "ask question": "The utterance contains a question about how to manipulate or move metabolites directly.",
            "clarify goal": "The speaker is exploring or defining the understanding of how metabolites interact or can be manipulated."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): What do you want it? You want it over there? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about the location or status of something."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I mean there's a there's a a huge amount of complexity. So I think. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): I'm asking you if you want it if it was there on purpose. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification about the intention behind something."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: You know, I mean it was supposed to be a bullet point under the one above but it didn't format it the way I thought it was going to. Somebody who's neurotypical and put it in somebody with autism and you change their behavior. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Is there anything additionally that I neglected to put on here? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on if there are any additional points that were not covered."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Does does not show we mentioned at some point. I don't see it anywhere. ",
        "annotations": {
            "ask question": "Judith Eisen is requesting information or clarification on a prior statement or idea, indicating she cannot find something they expected to be mentioned or shown."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): We did. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges a previous statement or action, showing recognition of a contribution made."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: You know, I don't know if we want to call it out or not. In in my perspective doing that experiment then gives you the hypothesis that you can start testing. ",
        "annotations": {
            "Develop idea": "The utterance develops the idea of experimental design and the importance of generating testable hypotheses.",
            "Clarify goal": "The utterance clarifies the goal of conducting experiments to generate hypotheses that can be tested."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Yeah, there you go. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging a previous contribution.",
            "supportive response": "The speaker is expressing agreement or validation."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Well people generally feel that way or if you guys are happy with that we can go back to the funding discussion which is probably more high yield anyway. ",
        "annotations": {
            "process management": "Judith Eisen is managing the meeting flow by suggesting a transition to a different topic (funding discussion) which she considers more productive."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: We have a couple minutes left so. ",
        "annotations": {
            "process management": "The speaker is indicating awareness of the time constraint and suggesting they should be mindful of it, which involves managing the meeting's flow and time."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: What what do you think are? ",
        "annotations": {
            "encourage participation": "invites someone else in the group to contribute their expertise, opinions or ideas."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Are you guys okay with that? Are you all okay with that? ",
        "annotations": {
            "ask question": "The speaker is requesting information or confirmation from the group."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): I was sort of you know thinking about I'm sorry I didn't mean to like to but they were I was just trying to ensure and help tell other No, it was a high yield discussion and one that is definitely valuable. I just wanted to before we dumped out make sure that I was appropriately group centered on what I was reporting back. ",
        "annotations": {
            "code name": "process management",
            "explanation": "Lisa Ryno reflects on her contribution to ensure it aligns with the group's objectives."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Thank you. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: But I have to say in the microbiome field. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: In the early days students in my lab this is a field that has research based and there's a bias towards hypothesis. I don't fully buy into this hypothesis generated research. ",
        "annotations": {
            "signal expertise": "Judith Eisen is expressing her opinion based on her experience in the field.",
            "identify gap": "She implies a limitation in the current research approach, specifically the bias towards hypothesis-generated research.",
            "critical response": "She is providing a negative evaluation of the prevailing approach towards hypothesis-generated research."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): There's so much that we don't know you have to do observations before you can generate a hypothesis. So who's going to fund the observations? ",
        "annotations": {
            "ask question": "The speaker asks who will fund the observations, seeking information.",
            "identify gap": "The speaker recognizes a gap in knowledge, emphasizing the need for observations.",
            "encourage participation": "The question invites discussion on funding for observations."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: The way it's portrayed which in I mean it just seems ridiculous and and barrier and I don't know at least at my institution there's a fair amount of. ",
        "annotations": {
            "critical response": "The speaker expresses skepticism or frustration about the way research is portrayed or funded, indicating a critical response to current practices."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Snobbery. ",
        "annotations": {
            "critical response": "Lisa Ryno critiques the research community's attitude, calling it 'snobbery', which implies a negative evaluation of how certain types of research are perceived or funded."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: And it's easy way to see it portrayed and I have a fair amount of funding right now which is good for me but doesn't have the same cachet for promotion and tenure. Makes some people not think it's deeply enough. ",
        "annotations": {
            "develop idea": "The speaker is expanding on their thoughts about funding and its implications.",
            "critical response": "The speaker is critiquing how funding is perceived in their field.",
            "offer feedback": "The speaker is providing feedback on the situation with funding."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): That's a thing that for promotion and tenure you have an R1. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: And it's how you would actually get it causation versus correlation which is where we started. ",
        "annotations": {
            "summarize conversation": "The speaker is reflecting back on the conversation, referencing the discussion on causation versus correlation, indicating a summary of previous points.",
            "clarify goal": "The utterance also touches on the aspect of understanding goals or objectives, specifically in the context of determining causation versus correlation."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Maybe shouldn't. ",
        "annotations": {
            "None": "No relevant code explicitly applies to this utterance"
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: We're about we're about to be kicked out. I think they want to say something before. ",
        "annotations": {
            "process management": "The speaker is aware of the meeting time constraints and suggests that others might want to contribute before the session ends.",
            "encourage participation": "The speaker invites or suggests that others might want to say something before the session concludes."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Does anybody have any any closing thoughts? I'm sorry I got things wrong so don't have to take. No this has been great. ",
        "annotations": {
            "encourage participation": "The speaker invites others to contribute their thoughts or comments, encouraging participation.",
            "None": "No other relevant code applies to this utterance as it does not explicitly propose, develop, question, signal expertise, identify gaps, acknowledge, support, criticize, offer feedback, summarize, express humor, manage process, assign tasks, clarify goals, or confirm decisions."
        }
    },
    {
        "utterance": "Mike O'Donnell, Yale: I think what you just said sounded great. That was a great discussion. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive sentiment towards the discussion, indicating that they found it great."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Thanks for the discussion. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Thank you. ",
        "annotations": {
            "acknowledge contribution": "The speaker verbally recognizes another group member's input or contribution."
        }
    },
    {
        "utterance": "Aida Ebrahimi, Penn State (she/her): Thanks for recording. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Elizabeth Bess, UC Irvine: Great job. Thank you. I'm sorry I got kicked out. ",
        "annotations": {
            "supportive response": "The speaker is expressing agreement and a positive evaluation of the discussion or presentation."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: I thought this was I thought this was really interesting. You were you were back fast. It's good. time is just wonderful so thanks very much. ",
        "annotations": {
            "supportive response": "The speaker expresses a positive evaluation and appreciation for the discussion, indicating agreement and validation of the conversation."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Very interesting perspectives on it. On the NIH keep on pursuing it and talk to program directors that's my advice because I I actually have to R1s funded and it wouldn't have happened if I hadn't talked to program directors and pursuing it and. ",
        "annotations": {
            "signal expertise": "Judith Eisen shares her experience of having R1s funded, indicating her expertise.",
            "supportive response": "The tone is supportive as Judith offers advice.",
            "process management": "Judith provides advice on navigating the NIH funding process."
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Piki. ",
        "annotations": {
            "express humor": "The speaker makes a joke or a playful sound."
        }
    },
    {
        "utterance": "Lisa Ryno, Oberlin College (she/her): Yeah honorary member of the group. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Judith Eisen, University of Oregon Institute of Neuroscience: Very nice calm to me. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    }
]